BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 49 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,427 | -96.4% | 97,088 | -40.3% | 0.00% | -100.0% |
| Q1 2023 | $537,085 | +1828.9% | 162,753 | +858.6% | 0.00% | – |
| Q4 2022 | $27,844 | -58.4% | 16,978 | -29.7% | 0.00% | – |
| Q2 2022 | $67,000 | -59.4% | 24,134 | -50.8% | 0.00% | – |
| Q1 2022 | $165,000 | -35.3% | 49,097 | -26.2% | 0.00% | – |
| Q1 2021 | $255,000 | -45.6% | 66,512 | -35.9% | 0.00% | -100.0% |
| Q4 2020 | $469,000 | +143.0% | 103,738 | +130.2% | 0.00% | 0.0% |
| Q4 2019 | $193,000 | -60.9% | 45,059 | -64.4% | 0.00% | -75.0% |
| Q3 2019 | $493,000 | +12.3% | 126,459 | +13.7% | 0.00% | 0.0% |
| Q2 2019 | $439,000 | +116.3% | 111,245 | +137.6% | 0.00% | +100.0% |
| Q1 2019 | $203,000 | +463.9% | 46,823 | +365.1% | 0.00% | – |
| Q4 2018 | $36,000 | +1100.0% | 10,067 | +1577.8% | 0.00% | – |
| Q2 2017 | $3,000 | -66.7% | 600 | -72.5% | 0.00% | – |
| Q1 2017 | $9,000 | -18.2% | 2,180 | -43.9% | 0.00% | – |
| Q4 2015 | $11,000 | +22.2% | 3,883 | 0.0% | 0.00% | – |
| Q3 2015 | $9,000 | -43.8% | 3,883 | -11.4% | 0.00% | – |
| Q2 2015 | $16,000 | – | 4,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weaver Consulting Group | 130,000 | $437,000 | 0.21% |
| Ikarian Capital, LLC | 304,161 | $1,022,000 | 0.13% |
| ABNER HERRMAN & BROCK LLC | 265,000 | $890,000 | 0.12% |
| S.C. Financial Services, Inc. | 15,285 | $51,000 | 0.06% |
| JMAC ENTERPRISES LLC | 45,430 | $153,000 | 0.04% |
| CFO4Life Group, LLC | 12,000 | $40,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 10,839 | $1,329,000 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 29,186 | $98,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 190,403 | $640,000 | 0.00% |